Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: Results from the Pediatric Oncology Group

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2121-2125

  Strother, D ^a   Van Hoff, J ^b   Rao, P V ^c   Smith, E I ^d   Shamberger, R C ^e   Halperin, E C ^f   Murray, K J ^g   Castleberry, R P ^h  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pediat Oncol Grp Stat Office   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h Pediat Oncol Grp Operations Off   (United States)

Author keywords

Chemotherapy; Histology; Shimada; Stage 2B 3 neuroblastoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; INFANT; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; INFANT; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031241017     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(97)00293-1     Document Type: Conference Paper

References (8)

1. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11(8), 1466-1477.
2. Haase GM, Wong K. Y., deLorimier A. A., Sather H. N., Hammond G. D. Improvement in survival after excision of primary tumor in Stage III neuroblastoma. J Pediatr Surg. 24:1989;194-200.
3. Haase GM, O'Leary MC, Ramsay KC, et al. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 1991, 26(9), 1119-1124.
4. Cecchetto G., Luzzatto C., Carli M., Guglielmi M., Zanesco L. The role of surgery in non-localized neuroblastoma. Analysis of 59 cases. Tumori. 69:1983;327-329.
5. Shamberger R. C., Allarde-Segundo A., Kozakewich H. P. W., Grier H. E. Surgical management of stage III and IV neuroblastoma: Resection before or after chemotherapy. J Pediatr Surg. 26:(9):1991;1113-1118.
6. Tsuchida Y, Yokoyama J, Kanedo M, et al. Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan. J Pediatr Surg 1992, 27(5), 616-622.
7. Matthay KK, Stram D, Seeger RC, et al. A prospective Children's Cancer Group study of stage II neuroblastoma treated with surgery alone. Proc ASCO 1993, 12, 414.
8. Kushner BH, Cheung NV, LaQuaglia MP, et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996, 14(2), 373-381.